Cancer treatment reports 1979-06-01

Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity.

R Catane, D D Von Hoff, D L Glaubiger, F M Muggia

Index: Cancer Treat. Rep. 63(6) , 1033-8, (1979)

Full Text: HTML

Abstract

A review of the clinical data on azaserine, DON, and azotomycin reveals that these agents have limited but definite antitumor activity. All three drugs are analogs of L-glutamine and contain a diazo group. They have been studied as single agents in a wide variety of human malignancies and have also been included in trials using combination chemotherapy. Most of these studies were performed early in the history of clinical trials and, therefore, the method of reporting results and the evaluation criteria were quite different from those in use today. A renewed interest in these agents has been triggered by the remarkable activity of DON and azotomycin against human tumor lines implanted into nude mice. On the basis of this activity and the clinical data we have compiled, we feel that new clinical trials with these agents are warranted.

Related Compounds

  • Azaserine

Related Articles:

Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope "tags".

2015-01-01

[MAbs 7(1) , 129-37, (2015)]

The LIV-I/LS system as a determinant of azaserine sensitivity of Escherichia coli K-12.

2004-08-01

[FEMS Microbiol. Lett. 237 , 73-77, (2004)]

Identification and characterization of genes related to the production of organic acids in yeast.

2012-05-01

[J. Biosci. Bioeng. 113(5) , 556-61, (2012)]

The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects.

2009-03-01

[Am. J. Physiol. Heart Circ. Physiol. 296(3) , H815-22, (2009)]

Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.

2007-01-01

[J. Mol. Cell. Cardiol. 42(1) , 177-85, (2007)]

More Articles...